Comparison of Long-Term Outcomes and Associated Factors between Younger and Older Rural Ischemic Stroke Patients.

all-cause mortality ischemic stroke ischemic stroke recurrence long-term outcomes long-term survival young stroke

Journal

Journal of clinical medicine
ISSN: 2077-0383
Titre abrégé: J Clin Med
Pays: Switzerland
ID NLM: 101606588

Informations de publication

Date de publication:
05 Mar 2022
Historique:
received: 10 01 2022
revised: 16 02 2022
accepted: 03 03 2022
entrez: 10 3 2022
pubmed: 11 3 2022
medline: 11 3 2022
Statut: epublish

Résumé

Introduction: The rise of ischemic stroke among young adults has stressed the need to understand their risk profiles and outcomes better. This study aimed to examine the five-year ischemic stroke recurrence and survival probability among young patients in rural Pennsylvania. Methods: This retrospective cohort study included first-time ischemic stroke patients from the Geisinger Health System between September 2003 and May 2014. The outcomes included all-cause mortality and ischemic stroke recurrence at five years. Kaplan-Meier estimator, cumulative incidence function, Cox proportional hazards model, and Cause-specific hazard model were used to examine the association of independent variables with the outcomes. Results: A total of 4459 first-time ischemic stroke patients were included in the study, with 664 (14.9%) patients in the 18−55 age group and 3795 (85.1%) patients in the >55 age group. In the 18−55 age group, the five-year survival probability was 87.2%, and the cumulative incidence of recurrence was 8%. Patients in the 18−55 age group had significantly lower hazard for all-cause mortality (HR = 0.37, 95% CI 0.29−0.46, p < 0.001), and non-significant hazard for five-year recurrence (HR = 0.81, 95% CI 0.58−1.12, p = 0.193) compared to the >55 age group. Chronic kidney disease was found to be associated with increased mortality in the 18−55 age group. Conclusion: In our rural population, younger ischemic stroke patients were at the same risk of long-term ischemic stroke recurrence as the older ischemic stroke patients. Identifying the factors and optimizing adequate long-term secondary prevention may reduce the risk of poor outcomes among younger ischemic stroke patients.

Identifiants

pubmed: 35268521
pii: jcm11051430
doi: 10.3390/jcm11051430
pmc: PMC8911514
pii:
doi:

Types de publication

Journal Article

Langues

eng

Références

Stroke. 1994 Jul;25(7):1360-5
pubmed: 8023350
Eur J Neurol. 2013 May;20(5):818-23
pubmed: 23293975
J Neurol Sci. 2021 Mar 15;422:117339
pubmed: 33592506
JAMA. 2013 Mar 20;309(11):1136-44
pubmed: 23512060
PLoS One. 2021 Feb 10;16(2):e0246877
pubmed: 33566870
Stroke. 2017 Nov;48(11):2925-2930
pubmed: 28986426
Nat Rev Neurol. 2014 Jun;10(6):315-25
pubmed: 24776923
Eur Stroke J. 2016 Mar;1(1):28-40
pubmed: 31008265
JAMA Neurol. 2017 Jun 1;74(6):695-703
pubmed: 28395017
Circulation. 2016 Feb 9;133(6):601-9
pubmed: 26858290
Neurology. 2002 Jul 9;59(1):26-33
pubmed: 12105303
Stroke. 2009 Aug;40(8):2698-703
pubmed: 19590052
Neurology. 2019 May 21;92(21):e2444-e2454
pubmed: 31019103
Vasc Health Risk Manag. 2015 Feb 24;11:157-64
pubmed: 25750539
Ther Adv Neurol Disord. 2020 Dec 18;13:1756286420971895
pubmed: 33414844
Stroke. 2013 Mar;44(3):870-947
pubmed: 23370205
Am J Prev Cardiol. 2020 Sep 09;3:100085
pubmed: 34327465
J Am Heart Assoc. 2019 Jan 8;8(1):e010370
pubmed: 30563428
Stroke Res Treat. 2010 Dec 20;2011:879817
pubmed: 21197408
Stroke. 1999 Nov;30(11):2320-5
pubmed: 10548665
Stroke. 2009 Apr;40(4):1195-203
pubmed: 19246709
J Neurol Neurosurg Psychiatry. 2014 May;85(5):509-13
pubmed: 24249786
Ann Neurol. 2013 Oct;74(4):592-601
pubmed: 23776015
J Neurol. 2004 Dec;251(12):1507-14
pubmed: 15645352
Stroke. 2012 Oct;43(10):2624-30
pubmed: 22798330

Auteurs

Durgesh Chaudhary (D)

Department of Neurology, Neuroscience Institute, Geisinger Health System, Danville, PA 17822, USA.

Michelle Anyaehie (M)

Department of Medical Education, Geisinger Commonwealth School of Medicine, Scranton, PA 18510, USA.

Francis Demiraj (F)

Dr. Kiran C. Patel College of Osteopathic Medicine, Nova Southeastern University, Davie, FL 33314, USA.

Shreya Bavishi (S)

Cell and Molecular Biology Department, Tulane University, New Orleans, LA 70118, USA.

Shima Shahjouei (S)

Department of Neurology, Neuroscience Institute, Geisinger Health System, Danville, PA 17822, USA.

Jiang Li (J)

Department of Molecular and Functional Genomics, Weis Center for Research, Geisinger Health System, Danville, PA 17822, USA.

Vida Abedi (V)

Department of Public Health Sciences, College of Medicine, The Pennsylvania State University, Hershey, PA 17033, USA.

Ramin Zand (R)

Department of Neurology, Neuroscience Institute, Geisinger Health System, Danville, PA 17822, USA.
Neuroscience Institute, The Pennsylvania State University, Hershey, PA 17033, USA.

Classifications MeSH